Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • High-dose opioid prescribing continues to climb in Canada

  • Sleep disorders widely undiagnosed in individuals with multiple sclerosis

  • Unemployment for doctoral scientists, engineers below American national average in 2013

  • Mindfulness protects adults' health from the impacts of childhood adversity

  • Epilepsy breakthrough may lead to non-pharmacological therapies

  • To curb violent tendencies, start young

  • Young women involve parent in abortion when anticipating support

  • Everyday discrimination impacts mental health

  • This is your brain on snacks: Brain stimulation affects craving, consumption

  • Largest ever study of awareness during general anesthesia identifies risk factors and consequences

  •